por
Brendon Nafziger, DOTmed News Associate Editor | March 28, 2011
Imaging entrepreneur Michael Friebe, Ph.D., is stepping down as managing director of Tomovation GmbH and the Northern and Central Europe business of Alliance Medical GmbH at the end of the month, DOTmed News has learned.
Friebe said he will continue as a consultant for the companies through September. Anthony van de Wal will be responsible for NCE reporting and communication to Alliance Medical, according to a statement from the company. He is finance director for the NCE business, according to his Linkedin page.
Alliance Medical told DOTmed News the new "structure" of the company and its subsidiary was still under development, but that the details would be worked out soon.
Ad Statistics
Times Displayed: 12565
Times Visited: 21 Final days to save an extra 10% on Imaging, Ultrasound, and Biomed parts web prices.* Unlimited use now through September 30 with code AANIV10 (*certain restrictions apply)
Friebe founded Tomovation, an MRI, CT and PET-CT services and investment company in the Rurh region of Germany, in 2003. He joined Warwick, UK-based Alliance Medical when it
bought Tomovation in September 2008.
Friebe currently has a number of irons in the fire: he serves as professor of medical imaging entrepreneurship at Technical University in Munich, Germany. He's also an investment partner with FVW Investments for Your Health, a med tech venture capital firm. And he chairs the advisory board of SurgicEye GmbH, a startup that makes intra-operative SPECT devices.
Alliance is a 22-year-old provider of outsourced diagnostic services in Europe, with offices in Germany, Ireland, Italy, the Netherlands, Spain, Poland and the UK. It also runs a fleet of more than a dozen mobile scanners throughout Europe.